ArthroCare diversifies by entering ENT (ear, nose and throat) market
This article was originally published in Clinica
Executive Summary
ArthroCare is to expand into the ear, nose and throat (ENT) market with its patented coblation technology and the formation of a new division, ENTec, to commercialise the technique. The expansion is part of ArthroCare's diversification strategy for its technology into markets other than arthroscopy.